Litcius/Paper detail

Survival outcomes of real world patients with metastatic hormone-sensitive prostate cancer who do not achieve optimal PSA response with intensified androgen deprivation therapy with docetaxel or androgen receptor pathway inhibitors

Georges Gebrael, Nicolas Sayegh, Vinay Mathew Thomas, Beverly Chigarira, Nishita Tripathi, Yeon Jung Jo, Haoran Li, Kamal Kant Sahu, Ayana Srivastava, Taylor Ryan McFarland, Benjamin L. Maughan, Umang Swami, Neeraj Agarwal

2023Prostate Cancer and Prostatic Diseases19 citationsDOI

Topics & Concepts

MedicineDocetaxelProstate cancerAndrogen deprivation therapyOncologyInternal medicineHazard ratioContext (archaeology)UrologyCancerPaleontologyBiologyConfidence intervalProstate Cancer Treatment and ResearchRadiopharmaceutical Chemistry and ApplicationsCancer, Lipids, and Metabolism
Survival outcomes of real world patients with metastatic hormone-sensitive prostate cancer who do not achieve optimal PSA response with intensified androgen deprivation therapy with docetaxel or androgen receptor pathway inhibitors | Litcius